Rare respiratory diseases
Conditions
Interventions
None listed
Sponsors
NPO CS-Lung
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with rare respiratory diseases such as empyema necessary to drainage, pulmonary Langerhans cell histiocytosis, pleuroparenchymal fibroelastosis, pulmonary alveolar proteinosis, and progressive fibrosing interstitial lung diseases
Exclusion criteria
Exclusion criteria: Patients without written informed concent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of first-line treatment in each disease | — |
Secondary
| Measure | Time frame |
|---|---|
| All practice patterns including diagnostic methods and survival data | — |
Countries
Japan
Contacts
Public ContactNobuhiro Kanaji
Kagawa University Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine
Outcome results
None listed